Open Access

[Retracted] Actin‑binding protein anillin promotes the progression of hepatocellular carcinoma in vitro and in mice

  • Authors:
    • Huanxia Jia
    • Zhenya Gao
    • Fang Yu
    • Hongfang Guo
    • Baoyu Li
  • View Affiliations

  • Published online on: July 17, 2023     https://doi.org/10.3892/etm.2023.12120
  • Article Number: 421
  • Copyright : © Jia et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

September-2023
Volume 26 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jia H, Gao Z, Yu F, Guo H and Li B: [Retracted] Actin‑binding protein anillin promotes the progression of hepatocellular carcinoma in vitro and in mice. Exp Ther Med 26: 421, 2023.
APA
Jia, H., Gao, Z., Yu, F., Guo, H., & Li, B. (2023). [Retracted] Actin‑binding protein anillin promotes the progression of hepatocellular carcinoma in vitro and in mice. Experimental and Therapeutic Medicine, 26, 421. https://doi.org/10.3892/etm.2023.12120
MLA
Jia, H., Gao, Z., Yu, F., Guo, H., Li, B."[Retracted] Actin‑binding protein anillin promotes the progression of hepatocellular carcinoma in vitro and in mice". Experimental and Therapeutic Medicine 26.3 (2023): 421.
Chicago
Jia, H., Gao, Z., Yu, F., Guo, H., Li, B."[Retracted] Actin‑binding protein anillin promotes the progression of hepatocellular carcinoma in vitro and in mice". Experimental and Therapeutic Medicine 26, no. 3 (2023): 421. https://doi.org/10.3892/etm.2023.12120